Glenmark’s consolidated revenue increases by 18.98 per cent to Rs 12,378.82 million for Q1 FY 13-14 Read more
Cheaper anti-cancer drug effective in treating most common cause of blindness in older adults Read more
‘’Piramal Enterprises’’ diagnostic division business is expected to touch Rs 100-crore mark in next one year’ Read more